Hubei Biocause Heilen Pharmaceutical Co., Ltd.
SZSE:301211.SZ
21.24 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 543.14 | 1,694.327 | 1,858.089 | 1,859.615 | 105.265 | 71.057 | 61.625 | 48.818 |
| Short Term Investments
| 1,093.556 | 129.4 | 103.976 | 0 | 240 | 291 | 65 | 0 |
| Cash and Short Term Investments
| 1,636.695 | 1,823.726 | 1,962.065 | 1,859.615 | 345.265 | 362.057 | 61.625 | 48.818 |
| Net Receivables
| 80.683 | 75.077 | 127.475 | 161.045 | 114.209 | 125.626 | 99.039 | 80.645 |
| Inventory
| 137.851 | 173.805 | 114.702 | 89.495 | 134.59 | 74.105 | 96.139 | 88.996 |
| Other Current Assets
| 19.387 | 26.341 | 22.654 | 19.016 | 9.588 | 13.651 | 167.352 | 132.315 |
| Total Current Assets
| 1,874.616 | 2,098.949 | 2,226.895 | 2,129.171 | 603.652 | 575.439 | 489.154 | 350.773 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 527.752 | 361.991 | 184.804 | 131.703 | 136.761 | 126.91 | 118.627 | 134.425 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 68.938 | 71.071 | 73.275 | 66.666 | 61.449 | 40.061 | 31.989 | 43.068 |
| Goodwill and Intangible Assets
| 68.938 | 71.071 | 73.275 | 66.666 | 61.449 | 40.061 | 31.989 | 43.068 |
| Long Term Investments
| -1,083.913 | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
| Tax Assets
| 2.047 | 2.195 | 1.279 | 1.524 | 1.384 | 1.838 | 0.222 | 0.245 |
| Other Non-Current Assets
| 1,099.215 | 12.365 | 11.469 | 1.24 | 0 | 1.317 | 0.244 | 6.386 |
| Total Non-Current Assets
| 614.039 | 447.622 | 270.826 | 201.133 | 199.594 | 170.125 | 151.082 | 184.125 |
| Total Assets
| 2,488.656 | 2,546.571 | 2,497.721 | 2,330.304 | 803.247 | 745.565 | 640.236 | 534.898 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 116.042 | 117.695 | 82.621 | 36.126 | 36.879 | 40.33 | 37.914 | 43.988 |
| Short Term Debt
| 0 | 0 | 0 | 0 | 0 | 20 | 6.5 | 57 |
| Tax Payables
| 4.78 | 14.266 | 20.429 | 14.461 | 23.973 | 26.745 | 14.756 | 4.335 |
| Deferred Revenue
| 0 | 0 | 104.291 | 6.341 | 14.032 | 159.706 | 41.551 | 30.327 |
| Other Current Liabilities
| 43.562 | 43.18 | 36.138 | 46.078 | 24.203 | 6.159 | 69.288 | 69.775 |
| Total Current Liabilities
| 164.384 | 175.141 | 208.909 | 103.006 | 99.087 | 252.94 | 128.457 | 175.099 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 3.625 | 5.155 | 5.391 | 0 | 0 | 0 | 110.5 | 40.5 |
| Deferred Revenue Non-Current
| 2.04 | 0 | 0.222 | 0.28 | 0.338 | 0.396 | 0.454 | 11.652 |
| Deferred Tax Liabilities Non-Current
| 8.919 | 7.492 | 5.659 | 4.243 | 3.428 | 3.978 | 0.951 | -11.652 |
| Other Non-Current Liabilities
| 0 | 2.098 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 14.583 | 14.745 | 12.313 | 4.523 | 3.766 | 4.375 | 111.905 | 52.152 |
| Total Liabilities
| 178.967 | 189.886 | 221.222 | 107.528 | 102.853 | 257.315 | 240.362 | 227.251 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 288 | 288 | 240 | 240 | 180 | 180 | 180 | 180 |
| Retained Earnings
| 207.555 | 262.2 | 198.438 | 156.137 | 46.177 | 81.345 | -18.944 | -66.68 |
| Accumulated Other Comprehensive Income/Loss
| 0 | -0 | 33.55 | 22.126 | 474.217 | 226.905 | 125.037 | 0 |
| Other Total Stockholders Equity
| 1,814.134 | 1,806.484 | 1,804.443 | 1,804.512 | 474.217 | 226.905 | 111.697 | 124.287 |
| Total Shareholders Equity
| 2,309.689 | 2,356.685 | 2,276.499 | 2,222.776 | 700.394 | 488.25 | 286.092 | 237.608 |
| Total Equity
| 2,309.689 | 2,356.685 | 2,276.499 | 2,222.776 | 700.394 | 488.25 | 399.874 | 307.648 |
| Total Liabilities & Shareholders Equity
| 2,488.656 | 2,546.571 | 2,497.721 | 2,330.304 | 803.247 | 745.565 | 640.236 | 534.898 |